Kusumoto, S. and Tachibana, T. (2020) “Central nervous system management remains an evidence gap in first-line tagraxofusp therapy for blastic plasmacytoid dendritic cell neoplasm. Comment on: ‘First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level’”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301865.